We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+23.21%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$99.5M
AUM Growth
+$4.62M
(+4.9%)
Cap. Flow
-$4.26M
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
44.59%
Holding
87
New
5
Increased
10
Reduced
44
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inogen
INGN
|
+$996K |
| 2 |
NeuroOne Medical Technologies
NMTC
|
+$923K |
| 3 |
Ondas Inc
ONDS
|
+$831K |
| 4 |
Perion Network
PERI
|
+$700K |
| 5 |
MDxHealth
MDXH
|
+$447K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLP
Cantaloupe
CTLP
|
+$1.85M |
| 2 |
Exagen
XGN
|
+$1.16M |
| 3 |
Village Farms International
VFF
|
+$798K |
| 4 |
Natera
NTRA
|
+$635K |
| 5 |
Fastenal
FAST
|
+$394K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.43% |
| 2 | Technology | 23.96% |
| 3 | Communication Services | 10.24% |
| 4 | Industrials | 4.64% |
| 5 | Consumer Staples | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Target
TGT
$65.6B
| $483K | 0.49% |
4,900
-500
| -9% | -$48K |
|
52
Bristol-Myers Squibb
BMY
$133B
| $483K | 0.49% |
10,430
-2,300
| -18% | -$113K |
|
53
ConocoPhillips
COP
$147B
| $471K | 0.47% |
5,250
-1,250
| -19% | -$112K |
|
54
General Mills
GIS
$19.1B
| $461K | 0.46% |
8,900
-2,550
| -22% | -$141K |
|
55
Sera Prognostics
SERA
$79.9M
| $363K | 0.36% |
131,000
-19,000
| -13% | -$47K |
|
56
ePlus
PLUS
$2.42B
| $361K | 0.36% |
5,000
| – | – |
|
57
Digi International
DGII
$2.63B
| $360K | 0.36% |
10,333
| – | – |
|
58
Intel
INTC
$455B
| $329K | 0.33% |
14,700
| – | – |
|
|
59
Fastenal
FAST
$54.7B
| $315K | 0.32% |
7,500
-9,700
| -56% | -$394K |
|
60
Donaldson
DCI
$10.9B
| $305K | 0.31% |
4,400
-2,500
| -36% | -$168K |
|
61
Biodesix
BDSX
$220M
| $299K | 0.3% |
52,986
| – | – |
|
62
BP
BP
$116B
| $275K | 0.28% |
9,200
| – | – |
|
63
BioLife Solutions
BLFS
$1.53B
| $269K | 0.27% |
12,500
-1,000
| -7% | -$22.5K |
|
64
Costco
COST
$422B
| $247K | 0.25% |
250
| – | – |
|
65
Johnson & Johnson
JNJ
$618B
| $244K | 0.25% |
1,600
| – | – |
|
66
Asure Software
ASUR
$232M
| $244K | 0.25% |
25,000
| – | – |
|
|
FPAY
67
DELISTED
FlexShopper
FPAY
| $223K | 0.22% |
185,550
| – | – |
|
68
Quest Diagnostics
DGX
$25.7B
| $216K | 0.22% |
1,200
| – | – |
|
69
Baxter International
BAX
$13.5B
| $209K | 0.21% |
6,900
-3,900
| -36% | -$118K |
|
70
Hain Celestial
HAIN
$45M
| $190K | 0.19% |
125,213
-10,000
| -7% | -$23.4K |
|
71
Celcuity
CELC
$4.21B
| $156K | 0.16% |
11,700
+350
| +3% | +$3.81K |
|
72
Myomo
MYO
$39M
| $133K | 0.13% |
61,400
-13,600
| -18% | -$49.3K |
|
73
Tactile Systems Technology
TCMD
$635M
| $114K | 0.11% |
11,200
-12,500
| -53% | -$143K |
|
74
CVRx
CVRX
$137M
| $96.1K | 0.1% |
+16,350
| New | +$113K |
|
75
Accuray
ARAY
$32M
| $95.9K | 0.1% |
70,000
+4,500
| +7% | +$6.66K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Perkins Capital Management held 87 positions worth $99.5M, up 4.9% from $94.8M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Perkins Capital Management withdrew a net $4.26M in Q2 2025, closing 4 positions and reducing 44 holdings. Its most notable exit was Cantaloupe, an estimated $1.85M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in Inogen worth $1.04M.
- Perkins Capital Management's largest Q2 2025 buy was Inogen: 148,050 shares worth $1.04M.
- Perkins Capital Management added most to Perion Network in Q2 2025, an estimated $700K increase.
- Perkins Capital Management's biggest Q2 2025 reduction was Exagen, cutting an estimated $1.16M.
- Perkins Capital Management fully exited Cantaloupe in Q2 2025, selling an estimated $1.85M.
- Perkins Capital Management's ten largest holdings make up 45% of its $99.5M portfolio in Q2 2025.
- Perkins Capital Management opened 5 new positions and closed 4 in Q2 2025.
- Perkins Capital Management's portfolio value rose 4.9% quarter-over-quarter to $99.5M.
Based on Perkins Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.